QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
NASDAQ:SMTI

Sanara MedTech (SMTI) Stock Forecast, Price & News

$31.59
-1.52 (-4.59%)
(As of 09/28/2023 ET)
Compare
Today's Range
$31.55
$33.30
50-Day Range
$33.11
$45.99
52-Week Range
$26.75
$50.18
Volume
16,823 shs
Average Volume
16,787 shs
Market Capitalization
$269.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$59.00

Sanara MedTech MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
86.8% Upside
$59.00 Price Target
Short Interest
Bearish
3.82% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.23mentions of Sanara MedTech in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.31) to $2.87 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

719th out of 969 stocks

Surgical Appliances & Supplies Industry

14th out of 21 stocks


SMTI stock logo

About Sanara MedTech (NASDAQ:SMTI) Stock

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

SMTI Price History

SMTI Stock News Headlines

New Breakthrough "Living Software" Has Been…
New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>
Sanara MedTech to Participate in Two Upcoming Conferences
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
SMTI - Sanara MedTech Inc.
Sanara MedTech: Q1 Earnings Insights
Earnings Outlook For Sanara MedTech
See More Headlines
Receive SMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter.

SMTI Company Calendar

Last Earnings
8/14/2023
Today
9/28/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SMTI
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$59.00
High Stock Price Forecast
$59.00
Low Stock Price Forecast
$59.00
Forecasted Upside/Downside
+86.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-7,940,000.00
Pretax Margin
-17.57%

Debt

Sales & Book Value

Annual Sales
$45.84 million
Book Value
$5.02 per share

Miscellaneous

Free Float
3,818,000
Market Cap
$269.15 million
Optionable
Not Optionable
Beta
1.82
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Ronald T. Nixon (Age 67)
    Exec. Chairman
  • Mr. Zachary B. FlemingMr. Zachary B. Fleming (Age 48)
    Chief Exec. Officer
    Comp: $593.64k
  • Mr. Michael D. McNeil (Age 58)
    CFO & Corp. Sec.
    Comp: $438.68k
  • Dr. Christopher A. Morrison FACHM (Age 53)
    FAPWCA, FCCWS, M.D., Pres of Telehealth Services
    Comp: $156k
  • Mr. Callon Nichols
    VP of Corp. Operations
  • Mr. Bill Fitzgerald
    Chief Compliance Officer
  • Ms. Tricia Matteson
    VP of Marketing
  • Dr. Rebecca Erin Mcmahon (Age 38)
    Pres of R&D
  • Mr. Ryan Phillips
    Pres of Biologics
  • Mr. Seth Yon
    Pres of Commercial













SMTI Stock - Frequently Asked Questions

Should I buy or sell Sanara MedTech stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sanara MedTech in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SMTI shares.
View SMTI analyst ratings
or view top-rated stocks.

What is Sanara MedTech's stock price forecast for 2023?

1 brokerages have issued 1 year target prices for Sanara MedTech's shares. Their SMTI share price forecasts range from $59.00 to $59.00. On average, they expect the company's stock price to reach $59.00 in the next year. This suggests a possible upside of 86.8% from the stock's current price.
View analysts price targets for SMTI
or view top-rated stocks among Wall Street analysts.

How have SMTI shares performed in 2023?

Sanara MedTech's stock was trading at $45.50 at the start of the year. Since then, SMTI shares have decreased by 30.6% and is now trading at $31.59.
View the best growth stocks for 2023 here
.

When is Sanara MedTech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our SMTI earnings forecast
.

How were Sanara MedTech's earnings last quarter?

Sanara MedTech Inc. (NASDAQ:SMTI) announced its earnings results on Monday, August, 14th. The company reported ($0.22) EPS for the quarter. The business earned $15.75 million during the quarter. Sanara MedTech had a negative trailing twelve-month return on equity of 21.41% and a negative net margin of 14.39%.

What other stocks do shareholders of Sanara MedTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC).

What is Sanara MedTech's stock symbol?

Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI."

Who are Sanara MedTech's major shareholders?

Sanara MedTech's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.06%), Geode Capital Management LLC (0.82%), State Street Corp (0.62%), Northern Trust Corp (0.37%), Citadel Advisors LLC (0.21%) and Quadrature Capital Ltd (0.21%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming.
View institutional ownership trends
.

How do I buy shares of Sanara MedTech?

Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sanara MedTech's stock price today?

One share of SMTI stock can currently be purchased for approximately $31.59.

How much money does Sanara MedTech make?

Sanara MedTech (NASDAQ:SMTI) has a market capitalization of $269.15 million and generates $45.84 million in revenue each year. The company earns $-7,940,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis.

How many employees does Sanara MedTech have?

The company employs 101 workers across the globe.

How can I contact Sanara MedTech?

Sanara MedTech's mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The official website for the company is www.wndm.com. The company can be reached via phone at (817) 529-2300 or via email at ir@sanaramedtech.com.

This page (NASDAQ:SMTI) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -